south korea peptide South Korea peptide therapeutics market

south korea peptide South Korea peptide therapeutics market - South Koreapeptides Retatrutide peptides

Hanmi South Korea has emerged as a significant player in the global peptide industry, with numerous companies specializing in research, development, and manufacturing.The South Korea Peptide Synthesis Marketwas valued at 7.86 billion in 2025and is projected to grow at a CAGR of 7.03% from 2026 to 2033, ... This burgeoning sector encompasses a wide range of applications, from pharmaceutical drug development and therapeutic treatments to advanced cosmetic ingredients. South Korean expertise spans peptide synthesis, bio-material innovation, and the creation of cutting-edge peptide-based products, catering to both domestic and international markets.

Leading Peptide Companies and Their Specializations

The landscape of peptide companies in South Korea is diverse, with key players focusing on distinct areas of expertise. Companies like HLB PEP CO., LTD2024年9月30日—SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide .... are noted for their specialization in developing peptide bio-materials and new drug products, positioning themselves as pioneers in the field. Prime Pharma Korea stands out as a leading manufacturer of research peptides, emphasizing quality verification with ISO 9001 certification and third-party COA testing.

CAREGEN has dedicated years to researching various human proteins, focusing on the structure and activity of peptides, which likely informs their product development. Other notable entities include CHA-Meditech Co.A&PEP hasdesignedover 30,000 different peptides for 16 years and synthesized the peptides according to the protocol. As a result of our focused research on ..., LtdThe country research report onSouth Korea peptide therapeutics marketis a customer intelligence and competitive study of the South Korea market.., NB Pharm, WellPep Co.ANYGEN CO., LTD.|Tokyo Future Style, Inc., Ltd., BioInfra Life Science Inc., and OliPass Corporation, all listed as exporters of peptides from South KoreaTop Peptide Therapeutics Companies in South Korea. ANYGEN CO., LTDThepeptideand oligonucleotide cdmo market inSouth Koreais expected to reach a projected revenue of US$ 138.5 million by 2033. A compound annual growth .... operates a GMP plant recognized as Korea's first facility tailored for the production of peptide drug raw materials, highlighting a commitment to regulatory compliance and specialized manufacturing. Peptron is another significant supplier, providing peptides to over 500 organizations, including universities, hospitals, and research institutes, with a global export reachSK pharmteco Invests 0 Million to Expand Global Small ....

Applications of Peptides in South Korea

Peptides from South Korea find their way into various high-value sectors.作者:JW Son·被引用次数:23—This review covers the development and clinical efficacy of various GLP-1-based therapeutics, exploring the challenges and future directions in obesity ... In the cosmetics industry, manufacturers are increasingly utilizing bioactive peptides derived from natural or marine sources. These ingredients are formulated into products aimed at skin soothing, collagen stimulation, improved elasticity, and the reduction of wrinkles and fine lines, making them a sought-after component in Korean skincare.Bioengineered amyloid peptide for rapid screening of ... Products like Tony Moly's Bio Ex Cell Peptide line exemplify this trendLinks | PEPTIDE INSTITUTE, INC..

Beyond cosmetics, the pharmaceutical and biotechnology sectors are robustKorean Peptide Products : r/KoreanBeauty. South Korea is actively involved in the development of peptide therapeutics, with companies contributing to research in areas such as RNA therapeutics and novel drug delivery systemsSouth Korea Peptide Therapeutics Market. The market for peptide synthesis in South Korea is projected for significant growth, indicating ongoing investment and innovationThe country research report onSouth Korea peptide therapeutics marketis a customer intelligence and competitive study of the South Korea market.. Furthermore, companies like SK pharmteco are expanding their capabilities in small molecule and peptide manufacturing, positioning themselves as global contract development and manufacturing organizations (CDMOs)作者:JW Son·被引用次数:23—This review covers the development and clinical efficacy of various GLP-1-based therapeutics, exploring the challenges and future directions in obesity .... The South Korean peptide and oligonucleotide CDMO market is also expected to see substantial revenue growth.ANYGEN CO., LTD.'s GMP plant isKorea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure ...

Research and Development Trends

Research and development remain at the forefront of South Korea's peptide industry. Initiatives range from developing novel peptide drug product manufacturing technologies to exploring applications in precision medicine. For instance, research into Bioengineered amyloid peptides for rapid screening of inhibitors against viruses like SARS-CoV-2 showcases the country's contribution to global health challenges. The development of Glucagon-Like Peptide-1 (GLP-1) based therapies for conditions like obesity also represents a key area of focus, with ongoing exploration of clinical efficacy and future directions.

Navigating the Market and Future Outlook

For those seeking peptide sources in South Korea, understanding the market dynamics is crucial.ANYGEN CO., LTD. While some companies focus on raw materials for laboratory use, such as SB-PEPTIDE, others cater to broader therapeutic and cosmetic applications. The demand for injectable peptides in Seoul, for example, indicates a growing interest in peptide therapies for personal use, though it's important to distinguish between research-grade and human-administrable products.

The overall outlook for the South Korea peptide market is positive, driven by technological advancements, a strong research infrastructure, and increasing consumer and industry demand. Companies are continually innovating, from designing custom peptides to scaling up production for global distribution. This dynamic environment positions South Korea as a key hub for peptide innovation and supply in the coming years.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.